Boston Scientific's Patent Suit Against J&J Heads To Jury

Law360, New York (July 1, 2005, 12:00 AM EDT) -- In the last of three lawsuits between Boston Scientific Corp. and Johnson & Johnson Inc. over patent rights to cardiovascular stent technology, the jury convened Friday to begin deliberations in Boston Scientific’s patent lawsuit against J&J.

Boston Scientific, which lost two earlier trials to J&J over the lucrative technology, claims J&J's Cypher drug-eluting stent infringes its patents.

In closing arguments on Thursday, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson didn’t infringe Boston Scientific’s patents, which he said were invalid.

“You don't...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.